Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the SkinE. Maubec, Marie‐Françoise Avril|Journal of Clinical Oncology|2011Cited by 463
Genome-wide association study identifies three new melanoma susceptibility lociJennifer H. Barrett, Joan Anton Puig‐Butille, Mark M. Iles et al.|Nature Genetics|2011Cited by 250
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibilityMaria Teresa Landi, Wei V. Chen, Katerina Kypreou et al.|Nature Genetics|2020Cited by 238
Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 casesB. Vergier, Jean‐Philippe Merlio, Martina Prochazkova‐Carlotti et al.|Modern Pathology|2010Cited by 140
NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer TreatmentAlexandra Frazao, Anne Caignard, Louise Rethacker et al.|Frontiers in Immunology|2019Cited by 95